L'IMPERIO, VINCENZO
 Distribuzione geografica
Continente #
NA - Nord America 9.008
AS - Asia 8.000
EU - Europa 6.151
SA - Sud America 1.176
AF - Africa 142
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 4
Totale 24.500
Nazione #
US - Stati Uniti d'America 8.736
SG - Singapore 3.326
IT - Italia 2.035
CN - Cina 1.695
VN - Vietnam 1.155
HK - Hong Kong 989
RU - Federazione Russa 988
BR - Brasile 944
DE - Germania 787
SE - Svezia 627
IE - Irlanda 470
GB - Regno Unito 248
KR - Corea 171
AT - Austria 161
FR - Francia 160
CA - Canada 154
IN - India 139
ID - Indonesia 137
FI - Finlandia 124
NL - Olanda 114
UA - Ucraina 113
AR - Argentina 88
MX - Messico 86
TR - Turchia 71
PL - Polonia 68
DK - Danimarca 67
ZA - Sudafrica 63
BD - Bangladesh 59
JP - Giappone 58
IQ - Iraq 44
EC - Ecuador 36
ES - Italia 36
PK - Pakistan 32
LT - Lituania 27
BE - Belgio 26
CO - Colombia 23
CH - Svizzera 18
SA - Arabia Saudita 18
UY - Uruguay 18
VE - Venezuela 18
AU - Australia 17
MA - Marocco 17
PY - Paraguay 17
PE - Perù 16
AE - Emirati Arabi Uniti 15
GR - Grecia 15
TN - Tunisia 14
PT - Portogallo 13
CL - Cile 12
EG - Egitto 12
UZ - Uzbekistan 9
CZ - Repubblica Ceca 8
JO - Giordania 8
PH - Filippine 8
AL - Albania 7
AZ - Azerbaigian 7
DO - Repubblica Dominicana 7
KE - Kenya 7
CR - Costa Rica 6
DZ - Algeria 6
IL - Israele 6
LV - Lettonia 6
PA - Panama 6
RS - Serbia 6
BG - Bulgaria 5
HU - Ungheria 5
IR - Iran 5
JM - Giamaica 5
LB - Libano 5
TH - Thailandia 5
TW - Taiwan 5
BO - Bolivia 4
BY - Bielorussia 4
KZ - Kazakistan 4
MY - Malesia 4
NO - Norvegia 4
NP - Nepal 4
SK - Slovacchia (Repubblica Slovacca) 4
SN - Senegal 4
AM - Armenia 3
AO - Angola 3
GA - Gabon 3
GE - Georgia 3
OM - Oman 3
SC - Seychelles 3
BH - Bahrain 2
ET - Etiopia 2
EU - Europa 2
HN - Honduras 2
KG - Kirghizistan 2
LK - Sri Lanka 2
LY - Libia 2
MU - Mauritius 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BN - Brunei Darussalam 1
BT - Bhutan 1
Totale 24.486
Città #
Singapore 1.819
Ann Arbor 1.477
Ashburn 1.109
Hong Kong 979
Milan 607
Frankfurt am Main 476
Dublin 452
Dallas 419
Hefei 411
Fairfield 386
Ho Chi Minh City 366
Chandler 346
New York 321
Santa Clara 318
Los Angeles 297
Wilmington 291
Hanoi 280
Beijing 248
Houston 225
Woodbridge 219
Seattle 164
Seoul 157
Princeton 134
Dearborn 133
Buffalo 122
Cambridge 114
The Dalles 110
São Paulo 107
Jakarta 106
Shanghai 102
Vienna 102
Moscow 94
Munich 82
Jacksonville 81
Chicago 76
London 66
Rome 62
Nanjing 60
Warsaw 60
Helsinki 56
Denver 55
Dong Ket 54
Kent 53
Nuremberg 53
Altamura 52
Lawrence 50
Guangzhou 46
Montreal 46
Tokyo 46
Da Nang 43
Orem 40
Toronto 40
Florence 38
Stockholm 38
Johannesburg 37
Chennai 35
Monza 34
Phoenix 33
Boardman 32
Hải Dương 32
Poplar 31
Salt Lake City 31
Mexico City 30
Council Bluffs 29
Lissone 29
Haiphong 28
Lappeenranta 28
Atlanta 27
Brooklyn 27
Ha Long 27
Turku 27
Naples 26
Rio de Janeiro 26
Nanchang 24
Pune 24
Amsterdam 23
Brussels 23
Istanbul 23
San Diego 23
Boston 22
Cinisello Balsamo 22
Manchester 22
Turin 22
Bologna 21
Ankara 19
Biên Hòa 19
Changsha 19
Shenyang 19
Zhengzhou 19
Falls Church 18
Thái Nguyên 18
Tianjin 18
Bari 17
Düsseldorf 17
Ottawa 17
Quito 17
Quận Bình Thạnh 17
Sesto San Giovanni 17
Andover 16
Ninh Bình 16
Totale 14.789
Nome #
The putative role of MALDI-MSI in the study of Membranous Nephropathy 386
Rendering the invisible visible: adding a molecular dimension to pathology with spatial omics 351
Combined Plasmatic and Tissue Approach to Membranous Nephropathy-Proposal of a Diagnostic Algorithm Including Immunogold Labelling: Changing the Paradigm of a Serum-based Approach 349
MALDI imaging in Fabry nephropathy: a multicenter study 349
The proteomic landscape of renal tumors 345
MALDI-MSI Pilot Study Highlights Glomerular Deposits of Macrophage Migration Inhibitory Factor (MIF) as a Possible Indicator of Response to Therapy in Membranous Nephropathy 345
MALDI-MSI Approach to Renal Biopsies of Patients with Fabry Disease 333
Analysis of Hashimoto's thyroiditis on fine needle aspiration samples by MALDI-Imaging 325
Kidney Involvement 321
Ex vivo thyroid fine needle aspirations as an alternative for MALDI-MSI proteomic investigation: intra-patient comparison 317
Proteomic profiles of thyroid tumors by Mass Spectrometry-Imaging on Tissue Microarrays 308
High Spatial Resolution MALDI-MS Imaging in the Study of Membranous Nephropathy 308
Histoproteomic characterization of localized cutaneous amyloidosis in X-linked reticulate pigmentary disorder 304
Spatial resolution of renal amyloid deposits through MALDI-MSI: a combined digital and molecular approach to monoclonal gammopathies 291
Cytopathology of Bronchoalveolar Lavages in COVID-19 Pneumonia: A Pilot Study 286
Proteomics for the study of new biomarkers in Fabry disease: State of the art 284
Sequential MALDI-HiPLEX-IHC and Untargeted Spatial Proteomics Mass Spectrometry Imaging to Detect Proteomic Alterations Associated with Tumour Infiltrating Lymphocytes 282
"Pathologists in Venice - Real World Cases for an Immersive Training Experience": Education, Gaming, and Show 274
Proteome analysis in thyroid pathology 268
PD-L1 Testing and Squamous Cell Carcinoma of the Head and Neck: A Multicenter Study on the Diagnostic Reproducibility of Different Protocols 266
The "digital biopsy" in non-small cell lung cancer (NSCLC): a pilot study to predict the PD-L1 status from radiomics features of [18F]FDG PET/CT 262
Benchmarking digital displays (monitors) for histological diagnoses: the nephropathology use case 260
Granulomatosis with polyangiitis presenting with diffuse alveolar hemorrhage requiring extracorporeal membrane oxygenation with rapid multiorgan relapse: A case report 258
Digital counting of tissue cells for molecular analysis: the QuANTUM pipeline 248
Cytomolecular Classification of Thyroid Nodules Using Fine-Needle Washes Aspiration Biopsies 245
Clinicopathological characteristics of typical and atypical anti-glomerular basement membrane nephritis 244
Remission of low-grade lymphomatoid granulomatosis with extensive pulmonary involvement following immune restoration via antiretroviral therapy in a newly diagnosed HIV patient 240
α-1-Antitrypsin detected by MALDI imaging in the study of glomerulonephritis: Its relevance in chronic kidney disease progression 240
Debating the pros and cons of computational pathology at the European Congress of Pathology (ECP) 2024 239
Machine learning streamlines the morphometric characterization and multi-class segmentation of nuclei in different follicular thyroid lesions: everything in a NUTSHELL 230
Diagnostic performances of the acr-tirads system in thyroid nodules triage: A prospective single center study 228
Feasibility of MALDI-MSI-Based Proteomics Using Bouin-Fixed Pathology Samples: Untapping the Goldmine of Nephropathology Archives 226
Pediatric immune myelofibrosis (PedIMF) as a novel and distinct clinical pathological entity 225
Immunosuppression in idiopathic membranous nephropathy: A double-edge sword 223
Nodal monoclonal CD5-positive B-lymphocytosis and toxoplasma lymphadenitis: Another variant in the spectrum of infectious lymphadenitis in patients with chronic leukemia/small lymphocytic lymphoma 221
Use of diagnostic criteria from acr and eu-tirads systems to improve the performance of cytology in thyroid nodule triage 221
Spatially Resolved Molecular Approaches for the Characterisation of Non-Invasive Follicular Tumours with Papillary-like Features (NIFTPs) 216
Lipids, proteins, cells: advanced spatial multiomics to delve deeper into the complex molecular and cellular landscape of the tumour microenvironment 212
Lights on HBME-1: the elusive biomarker in thyroid cancer pathology 208
Digital transition in pathology lab: a survey from the Lombardy region 202
Dissecting the histological features of lupus nephritis highlights new common patterns of injury in class III/IV 199
Displaced Cartilage Within Lymph Node Parenchyma Is a Novel Biopsy Site Change in Resected Mediastinal Lymph Nodes Following EBUS-TBNA 199
More than an ‘atypical’ phenotype: dual molecular diagnosis of autoimmune lymphoproliferative syndrome and Becker muscular dystrophy 198
Routine immunohistochemical staining in membranous nephropathy: in situ detection of phospholipase A2 receptor and thrombospondin type 1 containing 7A domain 195
Improvements in digital pathology equipment for renal biopsies: updating the standard model 193
MALDI-MS imaging in the study of glomerulonephritis 191
Monoclonal gammopathy of renal significance: Systemic involvement by benign condition 188
The Complex Cyto-Molecular Landscape of Thyroid Nodules in Pediatrics 186
Destructuring glomerular diseases with structured deposits: challenges in the precision medicine era 185
Anticoagulant-related nephropathy: a pathological note 184
The therapeutic potential of an allosteric non-competitive CXCR1/2 antagonist for diabetic nephropathy 183
The value of the current histological scores and classifications of ANCA glomerulonephritis in predicting long-term outcome 179
Goodpasture syndrome and anti-glomerular basement membrane disease 176
Improving the Annotation Process in Computational Pathology: A Pilot Study with Manual and Semi-automated Approaches on Consumer and Medical Grade Devices 175
A Mass Spectrometry Imaging-based multiomics approach to map the tumour-immune landscape of clear cell Renal Cell Carcinoma and gain insights into resistance to immunotherapy 175
The routine use of a digital tool for the tumor cell fraction quantification in molecular pathology: an international validation of QuANTUM 174
The role of digital and integrative pathology for the detection of translocations: a narrative review 174
Congo Red Staining in Digital Pathology: The Streamlined Pipeline for Amyloid Detection Through Congo Red Fluorescence Digital Analysis 172
Clinical and histological findings at second but not at first kidney biopsy predict end-stage kidney disease in a large multicentric cohort of patients with active lupus nephritis 172
Tumour incidence in Fabry disease: A cross-sectional study 171
Proteomics and glomerulonephritis: A complementary approach in renal pathology for the identification of chronic kidney disease related markers 168
Monoclonal Gammopathy of Renal Significance: A Molecular Middle Earth between Oncology, Nephrology, and Pathology 167
An Indeterminate for Malignancy FNA Report Does Not Increase the Surgical Risk of Incidental Thyroid Carcinoma 166
Primary Sclerosing Cholangitis and Amyloid A Amyloidosis: Association or Coincidence? 166
Kidney Function, CKD Causes, and Histological Classification 166
Deep learning helps discriminate between autoimmune hepatitis and primary biliary cholangitis 163
The putative role of MALDI-MSI in the study of Membranous Nephropathy 163
Economic assessment of NGS testing workflow for NSCLC in a healthcare setting 162
Different clusters in patients with lupus podocytopathy identified by clinical-pathological characteristics 162
The putative role of MALDI-MSI in the study of Membranous Nephropathy 161
Digital pathology for the routine diagnosis of renal diseases: a standard model 161
#EBUSTwitter: Novel use of social media for conception, coordination, and completion of an international, multicenter pathology study 157
Pathology Laboratory Archives: Conservation Quality of Nucleic Acids and Proteins for NSCLC Molecular Testing 156
Artificial intelligence–based algorithms for the diagnosis of prostate cancer: A systematic review 154
MALDI-MS Imaging of glomerular diseases: A possible diagnostic role? 154
Liquid-based shaking of core needle biopsy samples for the molecular characterization of tumors: A fallback in cytopathology 154
Pathologist Validation of a Machine Learning-Derived Feature for Colon Cancer Risk Stratification 153
Un nuovo approccio basato sull’Imaging con Spettrometria di Massa per la sottotipizzazione dell’amiloidosi renale [A novel mass spectrometry imaging based approach for the subtyping of renal amyloidosisn] 149
6-Aza-2-Thiothymine as an Alternative Matrix for Spatial Proteomics with MALDI-MSI 149
Autopsia di Innocenzo XII. Un’attestazione dell’utilizzo del microscopio in ambito necroscopico nel XVII secolo 149
Digital twin manifesto for the pathology laboratory 149
Enhancing proteomics characterization of thyroid nodules: a pixel-classifier for mass spectrometry imaging analyses 148
MALDI-MS Imaging of glomerular diseases: A possible diagnostic role? 146
The Puzzle of Preimplantation Kidney Biopsy Decision-Making Process: The Pathologist Perspective 144
MALDI-MS imaging in glomerular kidney diseases: from diagnostics to precision medicine? 144
Renal involvement in eosinophilic granulomatosis with polyangiitis 143
JAK2-mutated Langerhans cell histiocytosis associated with primary myelofibrosis treated with ruxolitinib 142
Spatially Resolved Molecular Characterization of Noninvasive Follicular Thyroid Neoplasms with Papillary-like Nuclear Features (NIFTPs) Identifies a Distinct Proteomic Signature Associated with RAS-Mutant Lesions 140
Response to: 'Correspondence on 'Bowman's capsule rupture on renal biopsy improves the outcome prediction of ANCA-associated glomerulonephritis classifications'' by Hakroush and Tampe 140
High spatial resolution MALDI-MSI in the search for proteomic indicators of response to therapy in Membranous Nephropathy 139
Imaging molecolare a livello cellulare: possiamo predire la risposta alla terapia nella Nefropatia Membranosa? 138
Effect of Sustained Clinical Remission on the Risk of Lupus Flares and Impaired Kidney Function in Patients With Lupus Nephritis 137
Changing Phenotypes and Clinical Outcomes Over Time in Microscopic Polyangiitis 136
MALDI-MS Imaging in Membranous Nephropathy: from the research to the clinical laboratory? 136
Delving deeper into the Tumour Microenvironment: a MS-driven spatial multiomics approach to provide new molecular insights into immune-tumour cell communication 136
Automate the process of formalin-fixed paraffin-embedded blocks storage in the pathology laboratory: A proof of concept study 135
Paving the path toward multi-omics approaches in the diagnostic challenges faced in thyroid pathology 135
Digital Pathology Applications for PD-L1 Scoring in Head and Neck Squamous Cell Carcinoma: A Challenging Series 131
Cost analysis of archives in the pathology laboratories: from safety to management 131
Systemic vasculitis involving the kidney: the nephropathologist's point of view 130
Totale 20.569
Categoria #
all - tutte 84.254
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 84.254


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.128 0 0 0 0 0 170 166 198 148 159 120 167
2021/20221.189 145 131 127 68 68 101 26 79 33 83 123 205
2022/20231.928 185 503 193 146 106 275 53 144 164 41 81 37
2023/20241.950 67 85 86 121 190 442 351 70 175 40 87 236
2024/20256.832 234 517 624 277 469 287 329 219 645 1.000 884 1.347
2025/20269.225 1.962 1.303 1.414 2.009 1.864 673 0 0 0 0 0 0
Totale 25.164